Design, Synthesis, and Biological Evaluation of Analogues of the Antitumor Agent, 2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic Acid (XK469)
- 28 April 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (11) , 1758-1776
- https://doi.org/10.1021/jm0005149
Abstract
2-{4-[(7-Chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469) is among the most highly and broadly active antitumor agents to have been evaluated in our laboratories and is currently scheduled to enter clinical trials in 2001. The mechanism or mechanisms of action of XK469 remain to be elaborated. Accordingly, an effort was initiated to establish a pharmacophore hypothesis to delineate the requirements of the active site, via a comprehensive program of synthesis of analogues of XK469 and evaluation of the effects of structural modification(s) on solid tumor activity. The strategy formulated chose to dissect the two-dimensional parent structure into three regionsI, ring A of quinoxaline; II, the hydroquinone connector linkage; and III, the lactic acid moietyto determine the resultant in vitro and in vivo effects of chemical alterations in each region. Neither the A-ring unsubstituted nor the B-ring 3-chloro-regioisomer of XK469 showed antitumor activity. The modulating antitumor effect(s) of substituents of differing electronegativities, located at the several sites comprising the A-ring of region I, were next ascertained. Thus, a halogen substituent, located at the 7-position of a 2-{4-[(2-quinoxalinyl)oxy]phenoxy}propionic acid, generated the most highly and broadly active antitumor agents. A methyl, methoxy, or an azido substituent at this site generated a much less active structure, whereas 5-, 6-, 8-chloro-, 6-, 7-nitro, and 7-amino derivatives all proved to be essentially inactive. When the connector linkage (region II) of 1 was changed from that of a hydroquinone to either a resorcinol or a catechol derivative, all antitumor activity was lost. Of the carboxylic acid derivatives of XK469 (region III), i.e., CONH2, CONHCH3, CON(CH3)2, CONHOH, CONHNH2, CN, or CN4H (tetrazole), only the monomethyl- and N,N-dimethylamides proved to be active.Keywords
This publication has 14 references indexed in Scilit:
- Covalent Modification of Cyclooxygenase-2 (COX-2) by 2-Acetoxyphenyl Alkyl Sulfides, a New Class of Selective COX-2 InactivatorsJournal of Medicinal Chemistry, 1998
- In Vivo Methods for Screening and Preclinical TestingPublished by Springer Nature ,1997
- Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of miceCancer Letters, 1985
- A Facile Preparation of Aliphatic Hydroxamic Acid from N,N,O-Tris(Trimethylsilyl)Hydroxylamine and Acid ChlorideSynthetic Communications, 1983
- Boron trihalide-methyl sulfide complexes as convenient reagents for dealkylation of aryl ethersTetrahedron Letters, 1980
- Synthesis and chemistry of some 2-aminoethenesulfonyl fluorides. An unusual manganese dioxide oxidationThe Journal of Organic Chemistry, 1977
- Furazan Oxides. IV. Extensions of the Scope of the Haloalkoxy Substitution Reaction1a,bThe Journal of Organic Chemistry, 1964
- Quinoxaline derivatives—IIITetrahedron, 1964
- 2-AcyloxyacetylthiophenesJournal of the American Chemical Society, 1949
- Ueber die Reductions‐producte der nitrirten DimethylanilineEuropean Journal of Inorganic Chemistry, 1897